The inhibitory effect of human endothelial cell monolayers on platelet reactions and its inhibition by aspirin

This publication has 16 references indexed in Scilit:

• Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets
  Prostaglandins, 1977
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
  Prostaglandins, 1977
• Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
  Journal of Clinical Investigation, 1977
• HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
  The Lancet, 1977
• Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
  Prostaglandins, 1976
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976
• An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
  Nature, 1976
• Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release, and clot retraction
  Thrombosis Research, 1974
• Platelet Factor 3 Activity, Platelet Phospholipids and Their Fatty Acid and Aldehyde Pattern in Normal Male Subjects
  Scandinavian Journal of Clinical and Laboratory Investigation, 1968